Insights on the Global Clinical Trials Market Analysis 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Clinical Trials Market Analysis 2019” report has been added to ResearchAndMarkets.com’s offering.

The Global Clinical Trials market is expected to reach $69.41 billion by 2026 growing at a CAGR of 7.8% during 2018 to 2026.

A clinical trial is a type of research that studies a test or treatment given to people. Clinical trials study how safe and helpful tests and treatments are. When found to be safe and helpful, they may become tomorrow’s standard of care.

Some of the factors such as high R&D spending of the pharmaceutical industry and growing prevalence of disease and new disease cases are fuelling the market growth. However, lower healthcare reimbursement in the developing countries is restraining the market growth.

Based on Application, Oncology segment has witnessed significant growth due to the rise in number of disease cases and innovative headways that guide exact recognizable proof of illness causing cases and technological advancements that aid precise identification of ailment-causing organisms.

The key vendors mentioned are SGS SA, Wuxi AppTec Inc, QuintilesIMS, PRA Health Sciences, Pharmaceutical Product Development LLC, Parexel International Corporation, Novo Nordisk A/S, Laboratory Corporation Of America, INC Research, ICON Plc, Chiltern International Ltd and Charles River Laboratory.

Key Questions Answered in this Report:

• How this market evolved since the year 2016
• Market size estimations, forecasts and CAGR for all the segments presented in the scope
• Key Market Developments and financials of the key players
• Opportunity Analysis for the new entrants
• SWOT Analysis of the key players
• Fastest growing markets analyzed during the forecast period

Key Topics Covered:

1 Market Synopsis

2 Research Outline

2.1 Research Snapshot

2.2 Research Methodology

2.3 Research Sources

2.3.1 Primary Research Sources

2.3.2 Secondary Research Sources

3 Market Dynamics

3.1 Drivers

3.2 Restraints

4 Market Environment

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Clinical Trials Market, By Study Design

5.1 Introduction

5.2 Expanded Access

5.3 Interventional

5.4 Observational

6 Global Clinical Trials Market, By Phase

6.1 Introduction

6.2 Phase I

6.3 Phase II

6.4 Phase III

6.5 Phase IV

7 Global Clinical Trials Market, By Indication

7.1 Introduction

7.2 Pain management

7.3 Ophthalmology

7.4 Oncology

7.5 Obesity

7.6 Nose

7.7 Musculoskeletal

7.8 Metabolic

7.9 Mental disorders

7.10 Infections

7.11 Genitourinary

7.12 Gastrointestinal

7.13 Ear

7.14 Diabetes

7.15 Dermatology

7.16 CVS

7.17 Congenital

7.18 CNS condition

7.19 Circulatory

7.20 Cardiovascular

7.21 Cancer

7.22 Blood disorders

7.23 Autoimmune

8 Global Clinical Trials Market, By End User

8.1 Introduction

8.2 Dental Academic

8.3 Dental Hospitals & Clinics

8.4 Dental Institutes

8.5 Research Institutes

9 Global Clinical Trials Market, By Geography

7.1 North America

7.2 Europe

7.3 Asia Pacific

7.4 South America

7.5 Middle East & Africa

10 Strategic Benchmarking

11 Vendors Landscape

11.1 SGS SA

11.2 Wuxi AppTec Inc

11.3 QuintilesIMS

11.4 PRA Health Sciences

11.5 Pharmaceutical Product Development LLC

11.6 Parexel International Corporation

11.7 Novo Nordisk A/S

11.8 Laboratory Corporation Of America

11.9 INC Research

11.10 ICON Plc

11.11 Chiltern International Ltd

11.12 Charles River Laboratory

For more information about this report visit https://www.researchandmarkets.com/r/hdsegq

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900